Oxycodone
Cervix Cancer
Instituto de Investigación Hospital Universitario La PazSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Cervix Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tisotumab Vedotin Seagen Inc. | Phase 2 | BB |
TECHNETIUM-99 Institut de Cancérologie de Lorraine | Phase 3 | B |
Vorinostat UNICANCER | Phase 2 | CCC |
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER OncoNano Medicine, Inc. | Phase 1/2 | CCC |
Vinorelbine UNICANCER | Phase 1/2 | CCC |
View all 14 →
Same molecule, other indications
Oxycodone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →